20 Nov 2012
'Enhancing Drug Quality: The benefits of kinetic and thermodynamic binding data in discovery' took place at SCI HQ, London on Tuesday 6 November and was organised by SCI's Fine Chemicals Group.
Available conference papers:
- Programme/Flyer
-
Target-drug interactions: first principles and their application to drug discovery
Chris Kruse, Pharma Plexus -
Biophysical techniques for measuring kinetic and thermodynamics of binding
Dirk Ullman, Evotec -
From the (k)off
Stephen Roughley, Vernalis -
Thermodynamics guided lead discovery and optimisation
Gyorgy Keseru, Gideon Richter -
Exploiting interaction kinetic analysis for lead discovery and optimisation
Helena Danielson, Beactica/Uppsala University -
Exploiting kinetics and thermodynamics in drug discovery
Geoff Holdgate, AstraZeneca
Visit Blog